I think it’s going to be more than 3 today…!
Does Lantus (Sanofi drug for diabetes) increase cancer risk?
Takeda‘s alogliptin (new diabetes treatment) – FDA says, more info please.
European Medicines Agency approves a variety pack of new drugs and expanded indications. Here’s the rundown.
Newest version of Elan rumors – Novartis perhaps buying the MS part of the portfolio? Could make sense, given Novartis’ recent entry into that therapeutic area.
Roche: bye-bye Accutane – Roche is pulling its Accutane acne medicine from the U.S. market after juries awarded at least $33 million in damages to users who blamed the drug for bowel disease. Roche notified the U.S. Food and Drug Administration today that it was withdrawing Accutane after a “reevaluation” of its product lines showed it faced serious challenges from generic competitors, company officials said in a statement...more
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff